Go Pro

Marchex (NASDAQ:MCHX) Shares Pass Above 200 Day Moving Average - Time to Sell?

Marchex logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Marchex shares rose above their 200-day moving average, reaching $1.85 before closing at $1.81, compared with a 200-day average of $1.62.
  • Analyst sentiment remains weak: Weiss Ratings reaffirmed a “sell (D-)” rating, while the two analysts covering the stock rate it either Hold or Sell, resulting in a consensus “Reduce” rating.
  • The company’s latest quarter fell short of expectations, reporting a $0.01 per-share loss versus an expected $0.02 profit and revenue of $11.0 million versus $11.2 million expected; Marchex also posted negative net margin and return on equity.
  • Five stocks we like better than Marchex.

Marchex, Inc. (NASDAQ:MCHX - Get Free Report)'s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.62 and traded as high as $1.85. Marchex shares last traded at $1.81, with a volume of 12,563 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a "sell (d-)" rating on shares of Marchex in a research report on Friday, July 17th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Marchex currently has an average rating of "Reduce".

View Our Latest Stock Analysis on MCHX

Marchex Price Performance

The business has a 50-day moving average of $1.74 and a 200 day moving average of $1.62. The company has a market capitalization of $80.26 million, a PE ratio of -15.08 and a beta of 1.90.

Marchex (NASDAQ:MCHX - Get Free Report) last released its quarterly earnings results on Wednesday, August 12th. The technology company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.03). The firm had revenue of $11.00 million for the quarter, compared to analysts' expectations of $11.20 million. Marchex had a negative net margin of 12.44% and a negative return on equity of 18.25%.

Institutional Investors Weigh In On Marchex

Large investors have recently bought and sold shares of the business. Kanen Wealth Management LLC raised its stake in Marchex by 4.1% during the first quarter. Kanen Wealth Management LLC now owns 1,300,388 shares of the technology company's stock valued at $2,016,000 after purchasing an additional 50,989 shares in the last quarter. Acuitas Investments LLC bought a new stake in shares of Marchex in the 1st quarter worth about $207,000. Manatuck Hill Partners LLC purchased a new stake in shares of Marchex during the 2nd quarter valued at about $88,000. Jane Street Group LLC purchased a new stake in shares of Marchex during the 1st quarter valued at about $30,000. Finally, XTX Topco Ltd purchased a new stake in shares of Marchex during the 4th quarter valued at about $26,000. Institutional investors own 73.46% of the company's stock.

About Marchex

(Get Free Report)

Marchex, Inc NASDAQ: MCHX operates a call data and analytics platform designed to help businesses measure and optimize customer interactions. The company's core services include call tracking, conversational analytics and performance marketing solutions that attribute phone calls to specific advertising campaigns. By capturing and analyzing voice interactions, Marchex enables advertisers, agencies and brands to gain actionable insights into caller intent, marketing ROI and customer behavior.

Through its suite of technologies, Marchex offers real-time call monitoring, keyword spotting and AI-driven transcription to surface trends and conversion signals from inbound calls.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Marchex Right Now?

Before you consider Marchex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marchex wasn't on the list.

While Marchex currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines